Liverage Technology Inc. is a global leader in fiber optic components, optical transceivers, and advanced testing tools. With over 30 years of experience, we provide cutting-edge solutions …

Fatty Liver Disease Clinical Research Study recruiting participants. Learn more about our Fatty Liver Disease Research Study and Taking Part.

LIVERAGE will examine whether survodutide can improve MASH and/or fibrosis after 52 weeks of treatment and reduce the risk of end-stage liver disease outcomes after approximately seven …

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/ MASH Who Have Cirrhosis ClinicalTrials.gov ID NCT06632457

This study is open to adults who are at least 18 years old and have: * A confirmed liver disease called non-alcoholic steatohepatitis (NASH) or * A confirmed liver disease called metabolic …

Jun 6, 2015 · Liverage Technology Inc. is a leading manufacturer of high-quality optical transceivers, fiber optic components, and advanced testing equipment. With over 30 years of …

Nov 1, 2024 · LIVERAGE will examine whether survodutide can improve MASH and/or fibrosis after 52 weeks of treatment and reduce the risk of end-stage liver disease outcomes after …

The LIVERAGE™ and LIVERAGE™ Cirrhosis Studies are assessing the same study medication to see whether it might improve liver health for people with various stages of fatty liver disease.

Stay updated with Liverage’s latest innovations in fiber optic components, optical transceivers, and testing equipment. Discover how we lead the global market with cutting-edge solutions for …

There is no guarantee that you will benefit from taking part in either the LIVERAGE™ or LIVERAGE™ Cirrhosis Studies. However, you will receive in-depth, long-term monitoring of …